CSI Market
Sign In | Register

Kinnate Biopharma Inc (KNTE) Annual Balance Sheets

Annual · GAAP · USD millions
Access KNTE quarterly Balance Sheets →
Balance sheet data covering Kinnate Biopharma Inc– offers a view into how Dec 31 2023's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent57.00
Restricted Cash and Investments, Current, Total0.00
Short-term Investments, Total97.04
Cash & Short-term Investments153.00
Prepaid Expense And Other Assets Current4.14
Total Current Assets158.18
Equipment/Property/Plant Net3.81
Long-term investments10.26
Tax Assets, Noncurrent0.99
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset3.38
Restricted Cash Noncurrent0.37
Total Assets173.61
Liabilities
Accounts Payable, Current AC2.03
Accrued Liabilities, Current AC9.07
Other Liabilities, Current0.00
Total Current Liabilities12.00
Long-term debt0.40
Total Long-term Debt0.40
Financial Instruments, Insurance, Noncurrent0.26
Accrued Income Taxes, Noncurrent0.99
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent3.19
Operating Lease Liability Current0.99
Total Liabilities14.28
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock531.35
Retained Earnings / Accumulated Deficit-372.01
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity159.33
Non-controlling interests & other0.00
Total Stockholder's Equity159.33
Liabilities & Stockholder's Equity173.61
4 historic quarters locked

Sign in to unlock the full Kinnate Biopharma Inc balance sheet history.

Sign In Create Free Account

About Kinnate Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-24-016132

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License